Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sacchi

Leukemia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Leukemia|September 1, 1991
Leukaemia in Down's syndromeN Sacchi
Leukemia|June 1, 1996
DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cellsM Britos-Bray, N Sacchi, A D Friedman
Leukemia|January 1, 1988
High expression of ets-1 gene in human thymocytes and immature T leukemic cellsN Sacchi, A de Klein, S D Showalter, et al.
Leukemia|February 1, 1997
Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant cloneK van Lom, A Hagemeijer, F Vandekerckhove, et al.
Leukemia|January 22, 1998
Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patientsA Hagemeijer, A de Klein, J Wijsman, et al.
Leukemia|February 1, 1995
Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemiaG E de Greef, A Hagemeijer, R Morgan, et al.
Leukemia|October 26, 2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donorsF Locatelli, M Zecca, C Messina, et al.
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|July 10, 2013
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo OsseoE Todisco, F Ciceri, E Oldani, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Leukemia|September 1, 1991
Leukaemia in Down's syndromeN Sacchi
Leukemia|June 1, 1996
DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cellsM Britos-Bray, N Sacchi, A D Friedman
Leukemia|January 1, 1988
High expression of ets-1 gene in human thymocytes and immature T leukemic cellsN Sacchi, A de Klein, S D Showalter, et al.
Leukemia|February 1, 1997
Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant cloneK van Lom, A Hagemeijer, F Vandekerckhove, et al.
Leukemia|January 22, 1998
Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patientsA Hagemeijer, A de Klein, J Wijsman, et al.
Leukemia|February 1, 1995
Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemiaG E de Greef, A Hagemeijer, R Morgan, et al.
Leukemia|October 26, 2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donorsF Locatelli, M Zecca, C Messina, et al.
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|July 10, 2013
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo OsseoE Todisco, F Ciceri, E Oldani, et al.
Pageof 1